Paclitaxel DCB for coronary lesions: 12-month results. Do drug-coated balloons PREVAIL?

This abstract was presented at PCR e-Course 2020

Speaker: A. Latib

Summary

Consult this abstract to discover the PREVAIL trial results and the implications for drug-coated balloons in percutaneous coronary intervention.

Videos included on this page: the abstract presentation and an Investigator Perspective.

Speaker

Paclitaxel DEB for coronary lesions: 12-month results of the PREVAIL study

Download presentation

Speaker

Do drug-coated balloons prevail? (Sponsored by Medtronic)